Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 39, 2009 - Issue 5
433
Views
49
CrossRef citations to date
0
Altmetric
Research Article

In vitro stability and metabolism of salvinorin A in rat plasma

, , , , &
Pages 391-398 | Received 23 Oct 2008, Accepted 22 Jan 2009, Published online: 07 Apr 2009

References

  • Butelman ER, Harris TJ, Kreek MJ. (2004). The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology (Berlin) 172:220–4.
  • Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL. (2004). Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious κ-opioid receptor agonist: structural and functional considerations. J Pharmacol Exp Ther 308:1197–203.
  • Dean RA, Christian CD, Sample RHB, Bosron WF. (1991). Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J 5:2735–9.
  • Imai T. (2006). Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab Pharmacokinet 21:173–85.
  • Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O. (2005). Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol 70:1673–84.
  • Medana C, Massolino C, Pazzi M, Baiocchi C. (2006). Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry. Rapid Comm Mass Spectrom 20:131–6.
  • Minagawa T, Kohno Y, Suwa T, Tsuji A. (1995). Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases. Biochem Pharmacol 49:1361–5.
  • Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB. (2002). Salvinorin A: a potent naturally occuring nonnitrogenous κ opioid selective agonist. Proc Natl Acad Sci 99:11934–9.
  • Roth RH, Giarman NJ. (1966). γ-Butyrolactone and γ-hydroxybutyric acid – I. Distribution and metabolism. Biochem Pharmacol 15:1333–48.
  • Roth RH, Levy R, Giarman NJ. (1967). Dependence of rat serum lactonase upon calcium. Biochem Pharmacol 16:596–8.
  • Schmidt MS, Prisinzano TE, Tidgewell K, Harding W, Butelman ER, Kreek MJ, Murry DJ. (2005). Determination of salvinorin A in body fluids by high performance liquid chromatography- atmospheric pressure chemical ionization. J Chromatograph B 818:221–5.
  • Siebert DJ. (1994). Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 43:53–6.
  • Teiber JF, Draganov DI, La Du BN. (2003). Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Biochem Pharmacol 66:887–96.
  • Tidgewell K, Harding WW, Schmidt M, Holden KG, Murry DJ, Prisinzano TE. (2004). A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A. Bioorgan Med Chem Lett 14:5099–102.
  • Tougou K, Nakamura A, Watanabe S, Okuyama Y, Morino A. (1998). Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab Disposit 26:355–9.
  • Tsuji T, Kaneda N, Kado K, Yokokura T, Yoshimoto T, Tsuru D. (1991). CPT-11 converting enzyme from rat serum: purification and some properties. J Pharmacobio-Dynam 14:341–9.
  • Valdés III LJ. (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. J Psychoactive Drug 26:277–83.
  • Valdés III LJ, Díaz JL, Paul AG. (1983). Ethnopharmacology of Ska María Pastora (Salvia divinorum, Epling and Játiva-M.). J Ethnopharmacol 7:287–312.
  • Yamaori S, Fujiyama N, Kushihara M, Funahashi T, Kimura T, Yamamoto I, Sone T, Isobe M, Ohshima T, Matsumura K, Oda M, Watanabe K. (2006). Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis. Drug Metab Pharmacokinet 21:147–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.